Supernus Pharmaceuticals Inc (SUPN)
30.83
+0.56
(+1.85%)
USD |
NASDAQ |
May 03, 16:00
30.84
+0.01
(+0.03%)
After-Hours: 20:00
Supernus Pharmaceuticals Profit Margin (Quarterly): 0.72% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.72% |
| September 30, 2023 | -10.38% |
| June 30, 2023 | -0.61% |
| March 31, 2023 | 11.02% |
| December 31, 2022 | 15.23% |
| September 30, 2022 | 0.99% |
| June 30, 2022 | 4.63% |
| March 31, 2022 | 16.80% |
| December 31, 2021 | 1.54% |
| September 30, 2021 | 14.52% |
| June 30, 2021 | 16.79% |
| March 31, 2021 | 4.35% |
| December 31, 2020 | 21.43% |
| September 30, 2020 | 25.78% |
| June 30, 2020 | 27.36% |
| March 31, 2020 | 22.66% |
| December 31, 2019 | 32.98% |
| September 30, 2019 | 28.26% |
| June 30, 2019 | 31.26% |
| March 31, 2019 | 21.46% |
| December 31, 2018 | 22.33% |
| September 30, 2018 | 27.20% |
| June 30, 2018 | 30.88% |
| March 31, 2018 | 29.14% |
| December 31, 2017 | 15.44% |
| Date | Value |
|---|---|
| September 30, 2017 | 19.85% |
| June 30, 2017 | 22.90% |
| March 31, 2017 | 17.88% |
| December 31, 2016 | 22.96% |
| September 30, 2016 | |
| June 30, 2016 | 19.86% |
| March 31, 2016 | 10.92% |
| December 31, 2015 | 15.68% |
| September 30, 2015 | 9.95% |
| June 30, 2015 | 6.83% |
| March 31, 2015 | 2.57% |
| December 31, 2014 | 12.13% |
| September 30, 2014 | -10.45% |
| June 30, 2014 | 10.79% |
| March 31, 2014 | -171.2% |
| December 31, 2013 | -216.8% |
| September 30, 2013 | -1.92K% |
| June 30, 2013 | -9.74K% |
| March 31, 2013 | -12.53K% |
| December 31, 2012 | -1.24K% |
| September 30, 2012 | -14.82K% |
| June 30, 2012 | -11.00K% |
| March 31, 2012 | -4.46K% |
| December 31, 2011 | |
| September 30, 2011 | -88.49K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-10.38%
Minimum
Sep 2023
32.98%
Maximum
Dec 2019
13.96%
Average
15.23%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Dynavax Technologies Corp | 0.39% |
| Ligand Pharmaceuticals Inc | 64.72% |
| Pacira BioSciences Inc | 13.72% |
| Esperion Therapeutics Inc | -174.7% |
| Collegium Pharmaceutical Inc | 21.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.14% |
| Return on Assets | 0.09% |
| Return on Invested Capital | 0.12% |
| Gross Profit Margin (Quarterly) | 88.06% |
| Operating Margin (Quarterly) | 11.56% |
| Return on Net Operating Assets | 0.13% |